These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34794376)

  • 21. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
    Pohle T; Domschke W
    Langenbecks Arch Surg; 2000 Aug; 385(5):317-23. PubMed ID: 11026702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refractory Gastroesophageal Reflux Disease Successfully Treated with Endoscopic Anti-gastroesophageal Reflux Mucosal Resection by the ESD-G Method (with Video).
    Sasaki S; Ota K; Iwatsubo T; Sugawara N; Hakoda A; Tanaka H; Mori Y; Takeuchi T; Higuchi K; Nishikawa H
    Intern Med; 2024 Nov; 63(21):2923-2927. PubMed ID: 38432985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First Experience with Banded Anti-reflux Mucosectomy (ARMS) for GERD: Feasibility, Safety, and Technique (with Video).
    Hedberg HM; Kuchta K; Ujiki MB
    J Gastrointest Surg; 2019 Jun; 23(6):1274-1278. PubMed ID: 30734179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacotherapeutic management of gastroesophageal reflux disease (GERD).
    Chapelle N; Ben Ghezala I; Barkun A; Bardou M
    Expert Opin Pharmacother; 2021 Feb; 22(2):219-227. PubMed ID: 32893683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
    Yadlapati R; DeLay K
    Med Clin North Am; 2019 Jan; 103(1):15-27. PubMed ID: 30466671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton Pump Inhibitor Treatment Has Little Effects on Secretion of Saliva in Patients with Proton Pump Inhibitor-Responsive Mild Reflux Esophagitis and Non-Erosive Reflux Disease.
    Hoshikawa Y; Momma E; Hoshino S; Kawami N; Kitasako Y; Ikeda M; Iwakiri K
    Digestion; 2023; 104(3):187-192. PubMed ID: 36580899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors.
    Hongo M; Miwa H; Kusano M;
    J Gastroenterol Hepatol; 2012 May; 27(5):913-8. PubMed ID: 22142515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastroesophageal Reflux Disease-Related Disorders of Systemic Sclerosis Based on the Analysis of 66 Patients.
    Matsuda R; Yamamichi N; Shimamoto T; Sumida H; Takahashi Y; Minatsuki C; Kodashima S; Ono S; Niimi K; Tsuji Y; Sakaguchi Y; Saito I; Kataoka Y; Asada-Hirayama I; Kakimoto H; Yakabi S; Takeuchi C; Matsumoto Y; Tamaki Z; Fujishiro M; Asano Y; Sato S; Koike K
    Digestion; 2018; 98(4):201-208. PubMed ID: 30045036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.
    Shinozaki S; Osawa H; Kobayashi Y; Sakamoto H; Hayashi Y; Miura Y; Kawarai Lefor A; Yamamoto H
    Scand J Gastroenterol; 2018 Aug; 53(8):897-904. PubMed ID: 30056768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic full-thickness plication (Plicator) with two serially placed implants improves esophagitis and reduces PPI use and esophageal acid exposure.
    von Renteln D; Brey U; Riecken B; Caca K
    Endoscopy; 2008 Mar; 40(3):173-8. PubMed ID: 18322871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26121348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
    Kinoshita Y; Kato M; Fujishiro M; Masuyama H; Nakata R; Abe H; Kumagai S; Fukushima Y; Okubo Y; Hojo S; Kusano M
    J Gastroenterol; 2018 Jul; 53(7):834-844. PubMed ID: 29188387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes.
    Dunbar KB; Agoston AT; Odze RD; Huo X; Pham TH; Cipher DJ; Castell DO; Genta RM; Souza RF; Spechler SJ
    JAMA; 2016 May; 315(19):2104-12. PubMed ID: 27187303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study.
    Yoo IK; Ko WJ; Kim HS; Kim HK; Kim JH; Kim WH; Hong SP; Yeniova AÖ; Cho JY
    Surg Endosc; 2020 Mar; 34(3):1124-1131. PubMed ID: 31139995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy.
    Kawara F; Fujita T; Morita Y; Uda A; Masuda A; Saito M; Ooi M; Ishida T; Kondo Y; Yoshida S; Okuno T; Yano Y; Yoshida M; Kutsumi H; Hayakumo T; Yamashita K; Hirano T; Hirai M; Azuma T
    World J Gastroenterol; 2017 Mar; 23(11):2060-2067. PubMed ID: 28373773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic treatment of cardia lesions: the effects on gastroesophageal reflux disease.
    Liu X; Li Y; Zhou X; Huang Z; Dai X; Tang J; Cheng H
    Ann Palliat Med; 2021 Jun; 10(6):6669-6677. PubMed ID: 34154339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.